The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Ultibro Breezhaler

Novartis Europharm LimitedEU/1/13/862/001-006

Main Information

Trade NameUltibro Breezhaler
Active SubstancesIndacaterol maleate
Glycopyrronium bromide
Dosage FormInhalation powder, hard capsule
Licence HolderNovartis Europharm Limited
Licence NumberEU/1/13/862/001-006

Group Information

ATC CodeR03AL Adrenergics in combination with anticholinergics
R03AL04 indacaterol and glycopyrronium bromide


License statusAuthorised
Licence Issued19/09/2013
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back